Palvella Therapeutics, Inc. (PVLA) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to Palbella's third quarter 2025 financial results and corporate update conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there'll be a question and answer session. To ask a question during the session, you'll need to press star one one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one one again. Please be advised, today's conference is being recorded. I would like to hand the conference over to your speaker today. Bo Hanway, please go ahead. Thank you, Operator. Good morning, and thank you for joining the Palvela Therapeutics third quarter 2025 financial results and corporate update call. As a reminder, our press release detailing today's announcements can be found in the investor section of our website at www.palvelatx.com. On today's call, you will first hear from Wes Coffin, our founder and chief executive officer, followed by Dr. Jeff Martini, our chief scientific officer, and Matt Korenberg, our chief financial officer. Wes will return for closing remarks before we open the line for Q&A. Before we begin, please note that today's remarks may include forward-looking statements regarding our development programs, regulatory strategy, commercial planning, and financial outlook. These statements are based on current assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Please refer to our SEC filings for a full discussion of these risk factors. And now, I'll turn the call over to Wes. Thanks, Bohan, and good morning, everyone. As Palvella approaches our one-year anniversary as a public company next month, we've generated s...